quinoxalines has been researched along with carbostyril in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Flückiger, R; Gallop, PM; Greenspan, SL; Henson, E; Paz, MA | 1 |
| Catarzi, D; Cecchi, L; Colotta, V; Filacchioni, G; Lucacchini, A; Martini, C; Tacchi, P | 1 |
| Cordi, AA; Desos, P; Lepagnol, JM; Lestage, P; Morain, P | 1 |
| Erdõ, SL; Molnár, P | 1 |
| Behl, B; Hofmann, HP; Löscher, W; Potschka, H; Szabo, L; Treiber, HJ; Wlaź, P | 1 |
| Mead, AN; Stephens, DN | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Baskin, II; Palyulin, VA; Tikhonova, IG; Zefirov, NS | 1 |
| Balster, RL; Wiley, JL | 1 |
| Hoang, H; Ireland, CM; LaBarbera, DV; Mohammed, KA; Skibo, EB | 1 |
| Nelson, R; Pumariega, AJ; Rotenberg, L | 1 |
| Bag, S; Degani, MS; Tawari, NR | 1 |
| Arnoletti, E; Baragli, A; Ghè, C; Ghigo, E; Granata, R; Muccioli, G | 1 |
| Bonomo, RA; Chen, L; Coakley, P; Hujer, AM; Kreiswirth, BN; Marshall, SH; Paterson, DL; Perez, F; Rather, PN; Rudin, SD; Toltzis, P; van Duin, D | 1 |
| Chan, EW; Chen, S; Wong, MH | 1 |
| Chen, D; Hou, L; Lin, D; Liu, Z; Shen, G; Wang, Y; Ye, F; Yu, S; Zhang, J | 1 |
| Cortes, J; Muñoz-Couselo, E; Perez-Garcia, J; Racca, F; Soberino, J | 1 |
| He, ZP; Hu, GZ; Kuang, NN; Pan, YS; Sun, HR; Wang, YB; Wu, H; Yuan, L; Zhai, YJ | 1 |
| Ashton, TM; Herbert, KJ; Higgins, GS; Pirovano, G; Prevo, R | 1 |
| Huang, Y; Li, D; Sun, N; Wang, C; Yu, Q; Zhang, YX; Zhou, WX | 1 |
| Bassole, IHN; Bazié, BSR; Bougma, A; Hounhouigan, DJ; Kabré, E; Ouilly, JT; Sangaré, H; Savadogo, A; Scippo, ML; Séré, A | 1 |
2 review(s) available for quinoxalines and carbostyril
| Article | Year |
|---|---|
Targeting FGFR pathway in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Breast Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Female; Fibroblast Growth Factors; Humans; Naphthalenes; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinolines; Quinolones; Quinoxalines; Receptors, Fibroblast Growth Factor; Signal Transduction | 2018 |
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Drug Discovery; Humans; Indolizines; Mice; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Neoplasms; Quinolones; Quinoxalines; Thiophenes; Treatment Outcome | 2018 |
19 other study(ies) available for quinoxalines and carbostyril
| Article | Year |
|---|---|
Acid-promoted tautomeric lactonization and oxidation-reduction of pyrroloquinoline quinone (PQQ).
Topics: Chemical Phenomena; Chemistry; Coenzymes; Hydrolysis; Indicators and Reagents; Isomerism; Lactones; Mass Spectrometry; Oxidation-Reduction; PQQ Cofactor; Quinolones; Quinoxalines; Trifluoroacetic Acid | 1989 |
Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]qu
Topics: Animals; Cerebral Cortex; Corpus Striatum; In Vitro Techniques; Magnetic Resonance Spectroscopy; Protein Binding; Pyrazoles; Quinolones; Quinoxalines; Rats; Receptors, Purinergic P1; Structure-Activity Relationship | 1995 |
Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain; Brain Ischemia; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Gerbillinae; Kainic Acid; Mice; Molecular Structure; N-Methylaspartate; Neuroprotective Agents; Organophosphonates; Quinolones; Quinoxalines; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Xenopus | 1996 |
Differential effects of five glycine site antagonists on NMDA receptor desensitisation.
Topics: Animals; Benzothiadiazines; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glycine; Kynurenic Acid; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Quinolones; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1996 |
LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Imidazoles; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Quinolones; Quinoxalines; Receptors, AMPA; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Tritium | 1998 |
CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Operant; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred C57BL; Motor Activity; Quinolones; Quinoxalines; Receptors, AMPA; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1999 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
CoMFA and homology-based models of the glycine binding site of N-methyl-d-aspartate receptor.
Topics: Binding Sites; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Quinolones; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Regression Analysis; Sequence Homology, Amino Acid | 2003 |
Effects of modulators of N-methyl-D-aspartate receptor-mediated neurotransmission on diazepam discrimination in rats.
Topics: Amino Acids; Animals; Biguanides; Binding Sites; Conditioning, Operant; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; GABA Agonists; Male; N-Methylaspartate; Pentobarbital; Phencyclidine; Piperazines; Quinolones; Quinoxalines; Rats; Rats, Sprague-Dawley; Riluzole | 2004 |
Synthesis and biological evaluation of imidazoquinoxalinones, imidazole analogues of pyrroloiminoquinone marine natural products.
Topics: Animals; Antineoplastic Agents; Biological Products; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Humans; Imidazoles; Marine Biology; Mice; Pyrroles; Quinolones; Quinoxalines; Structure-Activity Relationship; Toxicity Tests, Acute | 2007 |
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzazepines; Bipolar Disorder; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotherapy; Quinolones; Quinoxalines; Smoking Cessation; Stress, Psychological; Varenicline | 2008 |
Pharmacophore mapping of a series of pyrrolopyrimidines, indolopyrimidines and their congeners as multidrug-resistance-associated protein (MRP1) modulators.
Topics: Computer Simulation; Humans; Hydrogen Bonding; Indoles; Inhibitory Concentration 50; Isoxazoles; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrimidines; Pyrroles; Quantitative Structure-Activity Relationship; Quinolones; Quinoxalines; Silymarin; Sulfonamides; Thiophenes | 2008 |
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B.
Topics: Acylation; Adipocytes; Adrenergic beta-Agonists; Animals; Benzimidazoles; Blotting, Western; Cells, Cultured; Class Ib Phosphatidylinositol 3-Kinase; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Drug Interactions; Ghrelin; Glycerol; Intra-Abdominal Fat; Isoproterenol; Lipolysis; Male; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; Quinoxalines; Rats; Rats, Wistar; Thiazolidinediones | 2011 |
OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.
Topics: Americas; Animals; Anti-Bacterial Agents; Asia; Australia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Quinolones; Quinoxalines; Swine; Swine Diseases | 2013 |
Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae.
Topics: Bacterial Proteins; Chloramphenicol; Drug Resistance, Bacterial; Enterobacteriaceae; Microbial Sensitivity Tests; Operon; Quinolones; Quinoxalines | 2015 |
Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1.
Topics: Antineoplastic Agents; Benzimidazoles; Biological Phenomena; Cell Line, Tumor; Drug Design; HeLa Cells; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quinolones; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 1; Structure-Activity Relationship; Vinyl Compounds | 2016 |
Identification and prevalence of RND family multidrug efflux pump oqxAB genes in Enterococci isolates from swine manure in China.
Topics: Animals; Anti-Bacterial Agents; Cell Division; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecalis; Escherichia coli; Fluoroquinolones; High-Throughput Nucleotide Sequencing; Manure; Membrane Transport Proteins; Microbial Sensitivity Tests; Operon; Plasmids; Polymerase Chain Reaction; Quinolones; Quinoxalines; Swine | 2018 |
Reduced D-Serine Release May Contribute to Impairment of Long-Term Potentiation by Corticosterone in the Perforant Path-Dentate Gyrus.
Topics: Animals; Corticosterone; Dentate Gyrus; Excitatory Amino Acid Antagonists; Long-Term Potentiation; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Open Field Test; Perforant Pathway; Phenols; Piperidines; Quinolones; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Serine | 2021 |
Assessment of heterocyclic aromatic amines contents in flamed and braised chicken in Burkina Faso.
Topics: Amines; Animals; Burkina Faso; Chickens; Chromatography, High Pressure Liquid; Cooking; Heterocyclic Compounds; Meat; Quinolones; Quinoxalines | 2022 |